Sex differences in dopamine- and vesicular monoamine-transporter functions: Implications for methamphetamine use and neurotoxicity

Annals of the New York Academy of Sciences

Volumn 1139, Issue , 2008, Pages 140-150

  Dluzen, D E ^a   McDermott, J L ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Addiction; Dopaminergic; Drug abuse; Estrogen; Gender differences; Nigrostriatal; Toxicity

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; NOMIFENSINE; POTASSIUM CHLORIDE; RESERPINE; VESICULAR MONOAMINE TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DEPOLARIZATION; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PROTEIN FUNCTION; SEX DIFFERENCE; SINGLE DRUG DOSE;

ANIMALIA; MUS;

EID: 53549094415     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1432.010     Document Type: Conference Paper

References (42)

1. Dluzen, D.E. & B. Liu. 2008. Gender differences in methamphetamine use and responses. Gend. Med. 5 : 24 35.
2. Westermeyer, J. & A.E. Boedicker. 2000. Course, severity and treatment of substance abuse among women versus men. Am. J. Drug Alcohol Abuse 26 : 523 535.
3. Brecht, M.L., A. O'Brien, C. von Mayrhauser & M.D. Anglin. 2004. Methamphetamine use behaviors and gender differences. Addict. Behav. 29 : 89 106.
4. Lin, S.K., D. Ball, C.C. Hsiao, et al. 2004. Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan. Psychiatry Clin. Neurosci. 58 : 206 212.
5. Hser, Y.I., E. Evans & Y.C. Huang. 2005. Treatment outcomes among women and men methamphetamine abusers in California. J. Subst. Abuse Treat. 28 : 77 85.
6. Wu, L-T., D.J. Pilowsky, W.L. Schlenger & D.M. Galvin. 2007. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community. Drug Alcohol Depend. 89 : 195 205.
7. National Institute of Justice. 1999. Report on Methamphetamine Uses in Five Western Cities. U.S. Department of Justice, National Institute of Justice. Washington, DC.
8. Kim, J.Y.S. & M. Fendrich. 2002. Gender differences in juvenile arrestees' drug use, self-reported dependence and perceived need for treatment. Psychiat. Serv. 53 : 70 75.
9. Rawson, R.A., R. Gonzales, J.L. Obert, et al. 2005. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response. J. Subst. Abuse Treat. 29 : 67 74.
10. Cretzmeyer, M., M.V. Sarrazin, D.L. Huber, et al. 2003. Treatment of methamphetamine abuse: research findings and clinical directions. J. Subst. Abuse Treat. 24 : 267 277.
11. Liu, B. & D.E. Dluzen. 2007. New research on methamphetamine abuse. Gender differences in methamphetamine effects: review of animal and human studies. In Drug and Alcohol Abuse Research Focus. T.A. Walcott, Ed. : 63 88. Nova Science Publishers.
12. Mattei, R. & E.A. Carlini. 1996. A comparative study of the anorectic and behavioral effects of fenproporex on male and female rats. Braz. J. Med. Biol. Res. 29 : 1025 1030.
13. Schindler, C.W., J.G. Bross & E.B. Thorndike. 2002. Gender differences in the behavioral effects of methamphetamine. Eur. J. Pharmacol. 442 : 231 235.
14. Milesi-Halle, A., H.P. Hendrickson, E.M. Laurenzana, et al. 2005. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats. Toxicol. Appl. Pharmacol. 209 : 203 213.
15. Roth, M.E. & M.E. Carroll. 2004. Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats. Psychopharmacology (Berl.) 172 : 443 449.
16. Chen, H.H., Y.K. Yang, et al. 2004. Methamphetamine-induced conditioned place preference is facilitated by estradiol pretreatment in female mice. Clin. J. Physiol. 46 : 169 174.
17. Hall, J.N. & P.M. Broderick. 1991. Community networks for response to abuse outbreaks of methamphetamine and its analogs. NIDA Res. Monogr. 115 : 109 120.
18. Munro, C.A., M.E. McCaul, D.F. Wong, et al. 2006. Sex differences in striatal dopamine release in healthy adults. Biol. Psychiatry 59 : 966 974.
19. Wagner, G.C., T.L. Tekirian & C.T. Cheo. 1993. Sexual differences in sensitivity to methamphetamine toxicity. J. Neural Transm. Gen. Sect. 93 : 67 70.
20. Yu, L. & P.C. Liao. 2000. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J. Neural Transm. 107 : 419 427.
21. Heller, A., N. Bubula, R. Lew, et al. 2001. Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug. J. Pharmacol. Exp. Ther. 298 : 769 779.
22. Dluzen, D.E., C. Tweed, L.I. Anderson & N.J. Laping. 2003. Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system. Neuroendocrinology 77 : 232 238.
23. Dluzen, D.E. & T.J. Salvaterra. 2005. Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice. Neuroendocrinology 82 : 78 86.
24. Kunnathur, V., K. Shemisa, B. Liu, et al. 2006. Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine. Neurotox. Teratol. 28 : 557 562.
25. Bhatt, S.D. & D.E. Dluzen. 2005. Dopamine transporter function differences between male and female CD-1 mice. Brain Res. 1035 : 188 195.
26. Walker, Q.D., M.B. Rooney, R.M. Wightman & C.M. Kuhn. 2000. Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience 95 : 1061 1070.
27. Lavalaye, J., J. Booij, L. Reneman, et al. 2000. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur. J. Nucl. Med. 27 : 867 869.
28. Mozley, L.H., R.C. Gur, P.D. Mozley & R.E. Gur. 2001. Striatal dopamine transporters and cognitive functioning in healthy men and women. Am. J. Psychiatry 158 : 1492 1499.
29. Staley, J.K., S. Krishnan-Sarin, S. Zoghbi, et al. 2001. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41 : 275 284.
30. Morissette, M., D. Biron & T. Di Paolo. 1990. Effect of estradiol and progesterone on striatal dopamine uptake sites. Brain Res. Bull. 25 : 419 422.
31. Morissette, M. & T. Di Paolo. 1993. Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 58 : 16 22.
32. Rivest, R., P. Falardeau & T. Di Paolo. 1995. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res. 692 : 269 272.
33. McArthur, S., H.E. Murray, A. Dhankot, et al. 2007. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition. J. Neurochem. 100 : 678 692.
34. Ji, J., J.L. McDermott & D.E. Dluzen. 2007. Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice. J. Neuroendocrinol. 19 : 725 731.
35. Dluzen, D.E., S. Bhatt & J.L. McDermott. 2008. Differences in reserpine-induced striatal dopamine output and content between female and male mice: Implications for sex differences in vesicular monoamine transporter 2 function. Neuroscience 154 : 1488 1496.
36. Disshon, K.A., J.W. Boja & D.E. Dluzen. 1998. Inhibition of striatal dopamine transporter activity by 17β-estradiol. Eur. J. Pharmacol. 345 : 207 211.
37. Disshon, K.A. & D.E. Dluzen. 1999. Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: influence of estrogen. Brain Res. 842 : 399 407.
38. Thompson, T.L. 1999. Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Res. 834 : 164 167.
39. Arvin, M., I. Fedorkova, K.A. Disshon, et al. 2000. Estrogen modulates responses of striatal dopamine neurons to MPP(+): evaluations using in vitro and in vivo techniques. Brain Res. 872 : 161 172.
40. i/o. Eur. J. Pharmacol. 511 : 121 126.
41. Karakaya, S., M. Kipp & C. Beyer. 2007. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. J. Neuroendocrinol. 19 : 682 690.
42. McDermott, J.L. & D.E. Dluzen. 2007. Aging and sex differences in striatal dopaminergic function. Neuroscience. 149 : 401 408.